Is Macquarie Healthcare I (DLHIX) a Strong Mutual Fund Pick Right Now?
Sector – Health fund seekers may want to consider taking a look at Macquarie Healthcare I (DLHIX). DLHIX possesses a Zacks Mutual Fund Rank of 3 (Hold), which is based on various forecasting factors like size, cost, and past performance.
We note that DLHIX is a Sector – Health fund, and this area is also loaded with various options. Sector – Health mutual funds give investors an opportunity to focus on one of the largest sectors of the American economy, healthcare. Funds in this category can include everything from for-profit hospitals to pharmaceutical companies and medical device manufacturers.
Macquarie is based in Philadelphia, PA, and is the manager of DLHIX. Macquarie Healthcare I made its debut in September of 2007, and since then, DLHIX has accumulated about $475.81 million in assets, per the most up-to-date date available. Liu Er Chen is the fund’s current manager and has held that role since September of 2007.
Obviously, what investors are looking for in these funds is strong performance relative to their peers. DLHIX has a 5-year annualized total return of 6.49% and is in the middle third among its category peers. Investors who prefer analyzing shorter time frames should look at its 3-year annualized total return of 6.73%, which places it in the top third during this time-frame.
It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower.
When looking at a fund’s performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, DLHIX’s standard deviation comes in at 12.85%, compared to the category average of 14.69%. The fund’s standard deviation over the past 5 years is 13.3% compared to the category average of 15.76%. This makes the fund less volatile than its peers over the past half-decade.
Investors should not forget about beta, an important way to measure a mutual fund’s risk compared to the market as a whole. DLHIX has a 5-year beta of 0.58, which means it is likely to be less volatile than the market average. Because alpha represents a portfolio’s performance on a risk-adjusted basis relative to a benchmark, which is the S&P 500 in this case, one should pay attention to this metric as well. DLHIX has generated a negative alpha over the past five years of -3.1, demonstrating that managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.
For investors, taking a closer look at cost-related metrics is key, since costs are increasingly important for mutual fund investing. Competition is heating up in this space, and a lower cost product will likely outperform its otherwise identical counterpart, all things being equal. In terms of fees, DLHIX is a no load fund. It has an expense ratio of 0.96% compared to the category average of 0.99%. Looking at the fund from a cost perspective, DLHIX is actually cheaper than its peers.
Investors should also note that the minimum initial investment for the product is $0 and that each subsequent investment has no minimum amount.
Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included.
Overall, Macquarie Healthcare I ( DLHIX ) has a neutral Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, average downside risk, and lower fees, Macquarie Healthcare I ( DLHIX ) looks like a somewhat average choice for investors right now.
This could just be the start of your research on DLHIXin the Sector – Health category. Consider going to www.zacks.com/funds/mutual-funds for additional information about this fund, and all the others that we rank as well for additional information. For analysis of the rest of your portfolio, make sure to visit Zacks.com for our full suite of tools which will help you investigate all of your stocks and funds in one place.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Get Your Free (DLHIX): Fund Analysis Report
This article originally published on Zacks Investment Research (zacks.com).